Skip to main content
Premium Trial:

Request an Annual Quote

Biogenes Technologies Raises $5.7M in Series A Round

NEW YORK — Biogenes Technologies, a Malaysian provider of genomic and molecular research products, said earlier this month that it has raised $5.7 million in Series A funding.

The money was provided by venture capital firm Pembangunan Ekuiti.

Founded in 2015, Biogenes designs and supplies a range of products for healthcare, ag-bio, food safety, and environmental testing applications including diagnostic biosensors, DNA immobilization probes, and aptamers.

The company said it will use the newly raised money to expand its commercial footprint in Southeast Asia and elsewhere.

"Biogenes will invest in a medical-grade manufacturing facility, advancing our technology portfolio, and expanding our sales outreach to the Southeast Asia region and other parts of the world," Biogenes Cofounder and CEO Tang Kok Mun said in a statement. "We [aim] to have the capacity to produce 10 million test kits [for aptamer-based diagnostics] per year."

The Scan

Cystatin C Plays Role in Immunosuppression, Cancer Immunotherapy Failure, Study Finds

A study in Cell Genomics provides insight into how glucocorticoids can lead to cancer immunotherapy failure via cystatin C production.

Aging, Species Lifespan Gene Expression Signatures Overlap

An Osaka Metropolitan University team reports in Nucleic Acids Research that transcriptional signatures of aging and maximum lifespan have similarities.

Splicing Subgroup Provides Protocols for Evaluating Splicing Variant Data

The group presents their approach on how to apply evidence codes to splicing predictions and other data in the American Journal of Human Genetics.

Single-Cell Transcriptomic Atlas of Mouse Cochlea to Aid Treatment Development

Researchers in PNAS conducted single-cell and single-nuclear sequencing of about 120,000 cells at three key timepoints in cochlear development to generate a transcriptomic atlas.